June 2018 Issue Table Of Contents
Source: Life Science Leader
![LSLEAD_COV1_June LSLEAD_COV1_June](https://vertassets.blob.core.windows.net/image/795c0e28/795c0e28-8397-4429-bf8c-e007c8bef905/375_250-lslead_cov1_june.jpg)
From The Editor
Feature Articles
- How Wild Ideas Fuel Regeneron’s George Yancopoulos
- Industry Explorers Blaze On: Vicki Sato — The Biology Biz
- Chris Garabedian On How To Drive Drug Development
Capitol Perspectives
Companies To Watch
CEO Corner
From Principles and Policy to Execution
Patient Perspectives
Industry Research
Inside The Industry
- Breaking Free Of Data Silos Demands A Comprehensive Strategy
- Pharma Needs A New Business Model
- Biopharma Startups Take Advantage Of Open IPO Window
- Pfizer Executives Elaborate On Biosimilar Goals, Challenges
- Being A Multicultural Millennial Female In Pharma Manufacturing
- Mapping The Swedish Precision Medicine Industry Landscape
Leadership Lessons
Ask The Board
- What Does Every Biopharmaceutical Executive Need To Know About California’s New Drug Pricing Transparency Law, And How Likely Is This To Spread To Other States And Why?
- Clinical Trials Continue To Increase In Complexity And Collect More Data. What Should Sponsors Do To Reduce The Costs Of Clinical Trials?
- Is There A Rise In Activist Investor Activity, And If So, What Is Driving It?
This website uses cookies to ensure you get the best experience on our website. Learn more